Drug intelligence / Profile preview

lidocaine (Phoenix Children's)

Development stage
Unknown
Lead developer
National Medical Products
Modality
Small Molecules
Administration
Intradermal
01

Overview

Buffered Lidocaine J-tip is a needle-free local anesthetic delivery system that combines 1% buffered lidocaine with the J-Tip jet injection device. Developed and studied by Phoenix Children's Hospital, this system is designed to manage procedural pain, particularly during lumbar punctures in pediatric and infant populations. The J-Tip device utilizes a compressed carbon dioxide (CO2) cartridge to deliver the anesthetic intradermally to a depth of 5–8 mm in approximately 0.2 seconds, bypassing the need for traditional needles. Lidocaine, the active pharmaceutical ingredient, is a small-molecule local anesthetic that functions by blocking voltage-gated sodium channels in nerve cell membranes. This action prevents the initiation and conduction of nerve impulses, thereby providing rapid local anesthesia. The addition of a buffering agent (typically sodium bicarbonate) to the lidocaine solution helps to reduce the stinging sensation upon injection and speeds the onset of the anesthetic effect.

Brand names
J-Tip
Other names
Buffered Lidocaine J-tipBuffered lidocaineNeedle-Free Jet Injection of Lidocaine
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on lidocaine (Phoenix Children's).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine (Phoenix Children's).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call